ICECURE MEDICAL LTD (ICCM)
IL0011224156 - Common Stock
ICECURE MEDICAL LTD
NASDAQ:ICCM (1/15/2025, 11:40:53 AM)
1.2
-0.04 (-3.23%)
Company Profile
IceCure Medical Ltd. is a commercial stage medical device company. The firm operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.
Company Info
ICECURE MEDICAL LTD
7 Ha'eshel St., PO Box 3163
CAESAREA
P: 97246230333
CEO: EYAL SHAMIR
Employees: 71
Website: https://icecure-medical.com/
ICCM News
2 days ago - IceCure MedicalIceCure Medical CEO Issues Letter to Shareholders & Reports Increase of 42% in ProSense® Sales for 2024 in North America/PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ('IceCure', 'IceCure Medical' or the 'Company'), developer of minimally-invasive cryoablation technology...
9 days ago - IceCure MedicalIceCure Medical Regains Full Nasdaq Compliance with Nasdaq Minimum Closing Bid Price Rule/PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology...
12 days ago - IceCure MedicalEuropean Patent Office Issues Intention to Grant Notice to IceCure for its Next-Generation Cryoablation Technology/PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology...
a month ago - IceCure MedicalData on IceCure's ProSense® Cryoablation for Low-Risk Breast Cancer Presented at Radiological Society of North America's 2024 Annual Meeting/PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology...
a month ago - IceCure MedicalIceCure's ProSense® Cryoablation Safe and Effective in Destruction of Kidney Tumors with 88.7% Recurrence-Free Rate Based on Interim ICESECRET Study Results/PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ('IceCure', 'IceCure Medical' or the 'Company'), developer of minimally-invasive cryoablation technology...
2 months ago - IceCure MedicalIceCure Medical Reports 36% Sales Growth in the First Nine Months of 2024 Driven by Global Adoption of ProSense® Cryoablation/PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology...
ICCM Twits
Here you can normally see the latest stock twits on ICCM, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
